Global Liquid Chromatography Market, - Global Forecast 2018 - 2026

The global Liquid Chromatography Market is expected to grow at a CAGR of 5 percent to USD 6 billion by 2026, up from USD 3.5 billion in 2018. The high sensitivity and precision of the HPLC technology, the expanding importance of HPLC tests in drug approvals, the growing use of hyphenated procedures, and rising pharmaceutical R&D spending are all driving this market's expansion. The high cost of HPLC systems, on the other hand, is projected to limit market expansion to some extent.

During the forecast period, HPLC instrument adoption is expected to rise.

The Liquid Chromatography Market will undoubtedly benefit from increased pharmaceutical, biotech, food, and agriculture research & development. Patented research and an increase in clinical trial enrollment will undoubtedly improve the market. During the projected period, the consumables market is expected to grow at the fastest rate.

During the projected period, the clinical research segment will increase at the fastest rate.

For clinical trials or research, an HPLC apparatus is essential. Inorganic impurities, such as plant or animal proteins, must be identified in pharmaceutical bulk materials, excipients, or catalysts. It can also be used to test organic substances. Clinical research entails evaluating a newly created medicine. This necessitates the use of effective analytical testing devices such as HPLC. As a result, this application has a substantial market share, which is followed by the use of HPLC in other applications (analysis of cosmetics, environmental studies, food industry etc.).

"During the forecast period (2018–2026), the market in North America is expected to develop at the fastest rate."

The greatest share of the worldwide HPLC market is predicted to come from North America. The increase in R&D funding, a growing number of preclinical activities by CROs and pharmaceutical companies, and the growing food and agricultural business in Canada are all driving market expansion in this region. Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. Extensive sales of biosimilars and generics in Japan, as well as expansion in the pharma and biotech sectors in India and China, are some of the primary drivers driving the growth of the HPLC market in this region.